Marina Gomez-Llobell

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Sep 18, 2025
Vaccination should not be forgotten in patients receiving immunoglobulin replacement therapy.

Sigrun Einarsdottir, Silvia Escribano-Serrat, Marina Gomez-Llobell

|Jul 24, 2025
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling.

Marina Gomez-Llobell, Carlos Serra Smith, Daniel Gómez-Costas

|Apr 21, 2025
T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy.

Kai Rejeski, Jaime Sanz, Teng Fei

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

Pageof 1

Frequent Collaborators

4 joint publications

Roni Shouval

4 joint publications

Miguel-Angel Perales

3 joint publications

Sigrun Einarsdottir

3 joint publications

Marion Subklewe